(marketscreener.com) EARNINGS/SALES RELEASESSurprisingly, ahead of its scheduled date, Demant reported weak Q2 preliminary numbers. The below expected performance was due to softness in the Hearing Aids and Diagnostics segments, whereas Hearing Care was in line with the management's expectations. Moreover, 2024 guidance was also downgraded, which was perhaps a major...https://www.marketscreener.com/quote/stock/DEMANT-A-S-56225597/news/Demant-Soft-Q2-guidance-downgrade-spooked-the-markets-47401466/?utm_medium=RSS&utm_content=20240717